P-001 · Type 2 Diabetes, Hypertension
10
Total Events
2024-11-28
Last Visit
2025-02-15
Next Scheduled
- Visit
Quarterly Diabetes Review
HbA1c improved to 7.1%. Medication dosage adjusted. Diet and exercise plan reinforced.
Dr. Sarah Chen
- Lab
Comprehensive Metabolic Panel
Fasting glucose: 118 mg/dL (borderline). Creatinine: 0.92 mg/dL (normal). eGFR: 78 mL/min.
Northbeam Reference Lab
- Vital
Remote Vital Sign Submission
Patient submitted home BP reading via patient portal: 118/74 mmHg. Pulse: 69 bpm.
Patient Self-Report
- Medication
Metformin Dose Increase
Metformin extended-release increased from 1000 mg to 1500 mg daily based on glycemic trends.
Dr. Sarah Chen
- Lab
HbA1c & Lipid Panel
HbA1c: 7.3% (improved from 7.8%). LDL: 94 mg/dL. HDL: 52 mg/dL. Total cholesterol: 176 mg/dL.
Helio Path Diagnostics
- Visit
Blood Pressure Follow-Up
BP trending down with lifestyle modifications. Continue current antihypertensive regimen.
Dr. Sarah Chen
- Note
Telehealth Consultation
Patient reports improved energy levels and reduced polyuria. Foot exam completed via video — no concerning findings.
Dr. Sarah Chen
- Medication
Lisinopril Prescribed
Lisinopril 10 mg daily initiated for blood pressure control. Patient counseled on ACE inhibitor side effects.
Dr. Sarah Chen
- Lab
Urinalysis with Microalbumin
Microalbumin/creatinine ratio: 28 mg/g. Borderline — repeat in 3 months. Urine culture negative.
Helio Path Diagnostics
- Visit
Annual Wellness Visit
Comprehensive annual exam. Referral placed for ophthalmology for diabetic eye screening. Flu vaccine administered.
Dr. Sarah Chen